메뉴 건너뛰기




Volumn 153, Issue 1, 2009, Pages 46-53

uPA and PAI-1 in Rectal Cancer-Relationship to Radiotherapy and Clinical Outcome

Author keywords

metastases; PAI 1; radiotherapy; rectal cancer; uPA

Indexed keywords

ANTIBIOTIC AGENT; FLUOROURACIL; FOLINIC ACID; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

EID: 63649152323     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.02.043     Document Type: Article
Times cited : (28)

References (35)
  • 1
    • 0035975394 scopus 로고    scopus 로고
    • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    • Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638
    • (2001) N Engl J Med , vol.345 , pp. 638
    • Kapiteijn, E.1    Marijnen, C.A.2    Nagtegaal, I.D.3
  • 2
    • 1842377447 scopus 로고    scopus 로고
    • Improved survival with preoperative radiotherapy in resectable rectal cancer
    • Swedish Rectal Cancer Trial
    • Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 (1997) 980
    • (1997) N Engl J Med , vol.336 , pp. 980
  • 3
    • 24944534960 scopus 로고    scopus 로고
    • Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
    • Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23 (2005) 5644
    • (2005) J Clin Oncol , vol.23 , pp. 5644
    • Folkesson, J.1    Birgisson, H.2    Pahlman, L.3
  • 4
    • 0031978182 scopus 로고    scopus 로고
    • Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study
    • discussion 549
    • Dahlberg M., Glimelius B., Graf W., et al. Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study. Dis Colon Rectum 41 (1998) 543 discussion 549
    • (1998) Dis Colon Rectum , vol.41 , pp. 543
    • Dahlberg, M.1    Glimelius, B.2    Graf, W.3
  • 5
    • 34248596246 scopus 로고    scopus 로고
    • Late adverse effects of radiation therapy for rectal cancer - a systematic overview
    • Birgisson H., Pahlman L., Gunnarsson U., et al. Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol 46 (2007) 504
    • (2007) Acta Oncol , vol.46 , pp. 504
    • Birgisson, H.1    Pahlman, L.2    Gunnarsson, U.3
  • 6
    • 3342929739 scopus 로고    scopus 로고
    • Effectiveness of preoperative staging in rectal cancer: Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?
    • Brown G., Davies S., Williams G.T., et al. Effectiveness of preoperative staging in rectal cancer: Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br J Cancer 91 (2004) 23
    • (2004) Br J Cancer , vol.91 , pp. 23
    • Brown, G.1    Davies, S.2    Williams, G.T.3
  • 7
    • 34247270703 scopus 로고    scopus 로고
    • Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: Implications for clinical trials
    • Smith N.J., Bees N., Barbachano Y., et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: Implications for clinical trials. Br J Cancer 96 (2007) 1030
    • (2007) Br J Cancer , vol.96 , pp. 1030
    • Smith, N.J.1    Bees, N.2    Barbachano, Y.3
  • 8
    • 33947187210 scopus 로고    scopus 로고
    • Recommendations for the reporting of surgically resected specimens of colorectal carcinoma
    • Jass J.R., O'Brien M.J., Riddell R.H., et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 38 (2007) 537
    • (2007) Hum Pathol , vol.38 , pp. 537
    • Jass, J.R.1    O'Brien, M.J.2    Riddell, R.H.3
  • 9
    • 33846595479 scopus 로고    scopus 로고
    • ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
    • Locker G.Y., Hamilton S., Harris J., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24 (2006) 5313
    • (2006) J Clin Oncol , vol.24 , pp. 5313
    • Locker, G.Y.1    Hamilton, S.2    Harris, J.3
  • 10
    • 34249881055 scopus 로고    scopus 로고
    • Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use
    • Duffy M.J., van Dalen A., Haglund C., et al. Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer 43 (2007) 1348
    • (2007) Eur J Cancer , vol.43 , pp. 1348
    • Duffy, M.J.1    van Dalen, A.2    Haglund, C.3
  • 11
    • 34547102747 scopus 로고    scopus 로고
    • Matrix metalloproteinases in rectal mucosa, tumor and plasma: Response after preoperative irradiation
    • Angenete E., Langenskiold M., Falk P., et al. Matrix metalloproteinases in rectal mucosa, tumor and plasma: Response after preoperative irradiation. Int J Colorectal Dis 22 (2007) 667
    • (2007) Int J Colorectal Dis , vol.22 , pp. 667
    • Angenete, E.1    Langenskiold, M.2    Falk, P.3
  • 12
    • 34648829019 scopus 로고    scopus 로고
    • Transforming growth factor beta-1 in rectal tumor, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients
    • Angenete E., Langenskiold M., Palmgren I., et al. Transforming growth factor beta-1 in rectal tumor, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients. Int J Colorectal Dis 22 (2007) 1331
    • (2007) Int J Colorectal Dis , vol.22 , pp. 1331
    • Angenete, E.1    Langenskiold, M.2    Palmgren, I.3
  • 13
    • 0033981473 scopus 로고    scopus 로고
    • The plasminogen activation system in tumor growth, invasion, and metastasis
    • Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57 (2000) 25
    • (2000) Cell Mol Life Sci , vol.57 , pp. 25
    • Andreasen, P.A.1    Egelund, R.2    Petersen, H.H.3
  • 14
    • 0036631895 scopus 로고    scopus 로고
    • Plasmin/plasminogen system in colorectal cancer
    • Berger D.H. Plasmin/plasminogen system in colorectal cancer. World J Surg 26 (2002) 767
    • (2002) World J Surg , vol.26 , pp. 767
    • Berger, D.H.1
  • 15
    • 0033801887 scopus 로고    scopus 로고
    • Urokinase-type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets
    • Yang J.L., Seetoo D., Wang Y., et al. Urokinase-type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Int J Cancer 89 (2000) 431
    • (2000) Int J Cancer , vol.89 , pp. 431
    • Yang, J.L.1    Seetoo, D.2    Wang, Y.3
  • 16
    • 0027935805 scopus 로고
    • Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
    • Ganesh S., Sier C.F., Griffioen G., et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54 (1994) 4065
    • (1994) Cancer Res , vol.54 , pp. 4065
    • Ganesh, S.1    Sier, C.F.2    Griffioen, G.3
  • 17
    • 0027968819 scopus 로고
    • Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer
    • Mulcahy H.E., Duffy M.J., Gibbons D., et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 344 (1994) 583
    • (1994) Lancet , vol.344 , pp. 583
    • Mulcahy, H.E.1    Duffy, M.J.2    Gibbons, D.3
  • 18
    • 0035911151 scopus 로고    scopus 로고
    • The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies
    • Bajou K., Masson V., Gerard R.D., et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152 (2001) 777
    • (2001) J Cell Biol , vol.152 , pp. 777
    • Bajou, K.1    Masson, V.2    Gerard, R.D.3
  • 19
    • 16844377832 scopus 로고    scopus 로고
    • Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease
    • Dellas C., and Loskutoff D.J. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93 (2005) 631
    • (2005) Thromb Haemost , vol.93 , pp. 631
    • Dellas, C.1    Loskutoff, D.J.2
  • 20
    • 0036354852 scopus 로고    scopus 로고
    • Prediction of distant metastases after curative surgery for rectal cancer
    • Gunther K., Dworak O., Remke S., et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103 (2002) 68
    • (2002) J Surg Res , vol.103 , pp. 68
    • Gunther, K.1    Dworak, O.2    Remke, S.3
  • 21
    • 0033573059 scopus 로고    scopus 로고
    • Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size
    • Abe J., Urano T., Konno H., et al. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size. Cancer 86 (1999) 2602
    • (1999) Cancer , vol.86 , pp. 2602
    • Abe, J.1    Urano, T.2    Konno, H.3
  • 22
    • 27144449936 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
    • Sakakibara T., Hibi K., Koike M., et al. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer 93 (2005) 799
    • (2005) Br J Cancer , vol.93 , pp. 799
    • Sakakibara, T.1    Hibi, K.2    Koike, M.3
  • 23
    • 0033835299 scopus 로고    scopus 로고
    • Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group
    • Nielsen H.J., Christensen I.J., Sorensen S., et al. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7 (2000) 617
    • (2000) Ann Surg Oncol , vol.7 , pp. 617
    • Nielsen, H.J.1    Christensen, I.J.2    Sorensen, S.3
  • 24
    • 0032515761 scopus 로고    scopus 로고
    • Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer
    • Nielsen H.J., Pappot H., Christensen I.J., et al. Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ 316 (1998) 829
    • (1998) BMJ , vol.316 , pp. 829
    • Nielsen, H.J.1    Pappot, H.2    Christensen, I.J.3
  • 25
    • 0037102368 scopus 로고    scopus 로고
    • Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424)
    • Harbeck N., Kates R.E., Look M.P., et al. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). Cancer Res 62 (2002) 4617
    • (2002) Cancer Res , vol.62 , pp. 4617
    • Harbeck, N.1    Kates, R.E.2    Look, M.P.3
  • 26
    • 0033014499 scopus 로고    scopus 로고
    • Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
    • Harbeck N., Thomssen C., Berger U., et al. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res Treat 54 (1999) 147
    • (1999) Breast Cancer Res Treat , vol.54 , pp. 147
    • Harbeck, N.1    Thomssen, C.2    Berger, U.3
  • 27
    • 71849104860 scopus 로고
    • Protein measurement with the folin phenol reagent
    • Lowry O., Rosebrough N.J., Farr A.L., et al. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265
    • (1951) J Biol Chem , vol.193 , pp. 265
    • Lowry, O.1    Rosebrough, N.J.2    Farr, A.L.3
  • 28
    • 0032414396 scopus 로고    scopus 로고
    • Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum
    • Richter K.K., Fink L.M., Hughes B.M., et al. Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. Am J Surg 176 (1998) 642
    • (1998) Am J Surg , vol.176 , pp. 642
    • Richter, K.K.1    Fink, L.M.2    Hughes, B.M.3
  • 29
    • 0037403588 scopus 로고    scopus 로고
    • The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumor pathology
    • Baker E.A., and Leaper D.J. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumor pathology. Eur J Cancer 39 (2003) 981
    • (2003) Eur J Cancer , vol.39 , pp. 981
    • Baker, E.A.1    Leaper, D.J.2
  • 30
    • 0033668753 scopus 로고    scopus 로고
    • Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression
    • Baker E.A., Bergin F.G., and Leaper D.J. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. Mol Pathol 53 (2000) 307
    • (2000) Mol Pathol , vol.53 , pp. 307
    • Baker, E.A.1    Bergin, F.G.2    Leaper, D.J.3
  • 31
    • 29744447032 scopus 로고    scopus 로고
    • Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation
    • Strup-Perrot C., Vozenin-Brotons M.C., Vandamme M., et al. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol 41 (2006) 60
    • (2006) Scand J Gastroenterol , vol.41 , pp. 60
    • Strup-Perrot, C.1    Vozenin-Brotons, M.C.2    Vandamme, M.3
  • 32
    • 0035878875 scopus 로고    scopus 로고
    • Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation
    • Zhao W., Spitz D.R., Oberley L.W., et al. Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res 61 (2001) 5537
    • (2001) Cancer Res , vol.61 , pp. 5537
    • Zhao, W.1    Spitz, D.R.2    Oberley, L.W.3
  • 33
    • 23844458933 scopus 로고    scopus 로고
    • Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene
    • Hageman J., Eggen B.J., Rozema T., et al. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 11 (2005) 5956
    • (2005) Clin Cancer Res , vol.11 , pp. 5956
    • Hageman, J.1    Eggen, B.J.2    Rozema, T.3
  • 34
    • 0345269072 scopus 로고    scopus 로고
    • Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial
    • Marijnen C.A., Nagtegaal I.D., Kapiteijn E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1311
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , pp. 1311
    • Marijnen, C.A.1    Nagtegaal, I.D.2    Kapiteijn, E.3
  • 35
    • 0031902286 scopus 로고    scopus 로고
    • Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    • Bajou K., Noel A., Gerard R.D., et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4 (1998) 923
    • (1998) Nat Med , vol.4 , pp. 923
    • Bajou, K.1    Noel, A.2    Gerard, R.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.